10x Genomics (TXG) Inventory (2018 - 2026)

10x Genomics (TXG) has 9 years of Inventory data on file, last reported at $53.5 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory fell 28.41% year-over-year to $53.5 million; the trailing twelve-month figure through Mar 2026 stood at $53.5 million (down 28.41% YoY), and the FY2025 full-year result was $56.3 million, down 32.21% from the prior year.
• Inventory retreated to $53.5 million in Q1 2026, from $56.3 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $94.0 million in Q3 2024 to a low of $53.5 million in Q1 2026.
• A 5-year average of $75.3 million and a median of $78.6 million in 2022 frame the typical range for Inventory.
• Across the five-year window, Inventory soared 65.42% in 2022 and slumped 34.12% in 2025, its largest moves.
• Tracing TXG's Inventory over 5 years: stood at $81.6 million in 2022, then slipped by 9.71% to $73.7 million in 2023, then climbed by 12.75% to $83.1 million in 2024, then slumped by 32.21% to $56.3 million in 2025, then retreated by 5.07% to $53.5 million in 2026.
• Business Quant data shows TXG's Inventory at $53.5 million in Q1 2026, $56.3 million in Q4 2025, and $62.0 million in Q3 2025.